No effects on morphological development had been observed in embryo-fetal enhancement studies with oral administration of methylphenidate to pregnant rats and rabbits in the course of organogenesis at doses approximately ten and fifteen times, respectively, the utmost encouraged human dose (MRHD) of sixty mg/working day specified to adolescents wit